Thromboembolic disease in pregnancy

被引:12
作者
Doyle, NM
Monga, M
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Houston, TX 77030 USA
[2] Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ogc.2004.03.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Venous thromboembolic disease is a major cause of maternal morbidity and mortality. Virchow's triad of hypercoagulability, venous stasis, and vascular damage all occur during pregnancy. The risk of venous thromboembolism is five to six times higher during pregnancy and the puerperium. Risk factors include age greater than 35, antiphospholipid antibodies, inherited thrombophilias, operative delivery, increased parity, obesity, mechanical heart valves, and family history. Prophylactic and therapeutic anticoagulation is recommended for women at risk. Low molecular weight heparins are safe and effective in most cases.
引用
收藏
页码:319 / +
页数:27
相关论文
共 79 条
  • [1] *AM COLL RAD, 2000, ACR STAND DIG IM DAT, P19
  • [2] Venous thromboembolism and pregnancy
    Andres, RL
    Miles, A
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (03) : 613 - +
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] Thrombophilia and pregnancy: Review of the literature and some original data
    Arkel, YS
    Ku, DHW
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (04) : 259 - 268
  • [5] BAHSON RR, 1985, AM J OBSTET GYNECOL, V152, P290
  • [6] BALLEGEER V, 1987, THROMB HAEMOSTASIS, V58, P1030
  • [7] BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744
  • [8] Bertina RM, 1997, CLIN CHEM, V43, P1678
  • [9] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [10] A pharmacokinetic study of dalteparin (Fragmin®) during late pregnancy
    Blombäck, M
    Bremme, K
    Hellgren, M
    Lindberg, H
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 343 - 350